Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reiter

Showing results (151-160 of 239) with videos related to

Pageof 24
Sort By:
Nuclear Medicine Communications|February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cellsAlexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Journal of Environmental Health|September 8, 2001
The potential health impacts of climate variability and change for the United States. Executive summary of the report of the health sector of the U.S. National AssessmentJ A Patz, M A McGeehin, S M Bernard, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 1998
First recorded outbreak of yellow fever in Kenya, 1992-1993. II. Entomologic investigationsP Reiter, R Cordellier, J O Ouma, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 29, 2019
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cellsFlorian P Reiter, Gerald Denk, Andreas Ziesch, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2022
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective studyDaniel Roessler, Osman Öcal, Alexander B Philipp, et al.
Oncology Research and Treatment|October 12, 2023
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center AnalysisStefan Munker, Daniel Roessler, Osman Öcal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2024
Reply to Muralidhar et al., Kenny et al., and Hotz et al.: The benefits of engagement with external research teamsRon S Jarmin, John M Abowd, Robert Ashmead, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2023
An in-depth examination of requirements for disclosure risk assessmentRon S Jarmin, John M Abowd, Robert Ashmead, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2019
Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl<sub>4</sub> mouse modelFlorian P Reiter, Liangtao Ye, Florian Bösch, et al.
Digestion|October 4, 2018
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Pageof 24

Showing results (151-160 of 239) with videos related to

Sort By:
Pageof 24
Nuclear Medicine Communications|February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cellsAlexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Journal of Environmental Health|September 8, 2001
The potential health impacts of climate variability and change for the United States. Executive summary of the report of the health sector of the U.S. National AssessmentJ A Patz, M A McGeehin, S M Bernard, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 1998
First recorded outbreak of yellow fever in Kenya, 1992-1993. II. Entomologic investigationsP Reiter, R Cordellier, J O Ouma, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 29, 2019
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cellsFlorian P Reiter, Gerald Denk, Andreas Ziesch, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2022
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective studyDaniel Roessler, Osman Öcal, Alexander B Philipp, et al.
Oncology Research and Treatment|October 12, 2023
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center AnalysisStefan Munker, Daniel Roessler, Osman Öcal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2024
Reply to Muralidhar et al., Kenny et al., and Hotz et al.: The benefits of engagement with external research teamsRon S Jarmin, John M Abowd, Robert Ashmead, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2023
An in-depth examination of requirements for disclosure risk assessmentRon S Jarmin, John M Abowd, Robert Ashmead, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2019
Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl<sub>4</sub> mouse modelFlorian P Reiter, Liangtao Ye, Florian Bösch, et al.
Digestion|October 4, 2018
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Pageof 24